Life Sciences Partial priority – G 1/15A new decision from the EPO’s Enlarged Board of Appeal marks a radical change in the EPO’s approach to assessing priority entitlement.Read More 03Feb2017 Employee inventor compensation – guidance from the UK Court of AppealThe UK Court of Appeal has upheld the decision of the High Court and the UK Intellectual Property Office that an employee of Unilever, Professor Shanks, was not entitled to inventor’s compensationRead More 01Feb2017 Update: Brexit and intellectual property rights in EuropeFollowing the UK's vote to leave the EU a few months ago, the UK is slowly beginning the long process of a negotiated exit.Read More 19Aug2016 The Unitary Patent & Unified Patent CourtGuide to Key Features & PerspectivesRead More 11Aug2016 Brexit and intellectual property rights in EuropeIn a referendum held on 23rd June 2016, the UK voted to leave the European UnionRead More 04Jul2016 EPO streamlines opposition processFrom 1st July 2016, the EPO will initiate a new streamlined opposition process. The intention is to bring opposition proceedings to a speedy conclusion and thereby establish legal certainty for all parties to the opposition proceedings and the public.Read More 02Jun2016 High Priority!Maintain the chain. Failure to maintain a precise and timely chain of title between priority and subsequent applications can cause loss of priority entitlement in Europe.Read More 01Jun2016 The Patent Box is Changing ShapeThe current UK Patent Box system is closing to new entrants from 30th June 2016.Read More 05May2016 Seattle Genetics (C-471/14): CJEU confirms that SPC terms are to be calculated from the date of notificationCJEU confirms that SPC terms are to be calculated from the date of notification of the marketing authorisation. It’s good news from the CJEU for those SPC owners who have been hoping for additional SPC term in Europe.Read More 06Oct2015 Seattle Genetics: Advocate General’s opinion points towards longer SPC termsGood news could be on the horizon for SPC owners hoping for additional SPC term in Europe, following the Advocate General’s (AG) opinion in the Seattle Genetics SPC referral currently being considered by the CJEU (C-471/14).Read More 10Sep201512345> Type Firm News Insights PodcastsServiceProtectDealDisputeSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026MayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
